首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1636377

2025-2033 年胰臟癌治疗和诊断市场报告（按类型（诊断、治疗）、应用（医院、诊所等）和地区）

Pancreatic Cancer Therapeutics and Diagnostics Market Report by Type (Diagnostics, Treatment), Application (Hospitals, Clinics, and Others), and Region 2025-2033

出版日期: 2025年01月10日 | 出版商:

IMARC | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024IMARC Group，全球胰臟癌治疗及诊断市场规模达45亿美元。蓬勃发展的医疗保健行业、胰腺癌患病率的上升以及对杀死胰腺癌细胞的化疗的需求不断增加是推动市场发展的一些关键因素。

胰臟癌治疗和诊断是用于诊断胰臟癌并提供治疗的医疗程序。这些治疗和诊断包括超音波、电脑断层扫描 (CT) 扫描、磁振造影 (MRI) 和正子断层扫描 (PET) 扫描。他们依靠超音波内视镜 (EUS)，使用超音波设备从腹部内部生成胰臟影像。由于胰臟细胞生长失控，它们有助于监测肿瘤的位置。他们协助进行活组织检查，取出一小部分组织样本，以便在显微镜下检查。它们还有助于实验室检查，例如全血细胞计数 (CBC)、胆道阻塞的肝臟酵素测试以及空腹血糖和糖化血红蛋白 (HbA1C) 测试。因此，胰臟癌的治疗和诊断在全球的医院和专科中心得到了应用。

胰臟癌治疗与诊断市场趋势：

目前，由于老年人口增加和群众过度吸烟习惯导致胰臟癌盛行率上升，是支撑市场成长的关键因素之一。除此之外，世界范围内分子生物学、药物和诊断技术的发展也在不断发展。这与蓬勃发展的医疗保健产业目前正在推动市场的成长。此外，透过阻止胰臟癌细胞生长和分裂来杀死胰臟癌细胞的化疗需求不断增加，对市场产生了积极影响。此外，多个国家的管理机构正在大力投资胰臟癌临床试验和脱氧核糖核酸（DNA）修復抑制剂合併化疗。他们也致力于透过批准临床阶段的药物来促进胰腺癌治疗和诊断的发展。除此之外，该行业的主要参与者正在推出一种人源化单株抗体，该抗体可促进抗肿瘤免疫反应，以治疗食道癌和胃食道交界处以及胰腺癌。他们也正在开发和推出基于试剂盒的测试，透过确定 BRCA1 和 BRCA2 变异并评估基因组不稳定性来检测胰臟癌，预计这将有助于未来几年市场的成长。

本报告回答的关键问题：

迄今为止，全球胰臟癌治疗和诊断市场的表现如何，未来几年将如何表现？
全球胰臟癌治疗和诊断市场的驱动因素、限制因素和机会是什么？
主要区域市场有哪些？
哪些国家代表了最具吸引力的胰臟癌治疗和诊断市场？
依类型划分市场是怎么样的？
胰臟癌治疗和诊断市场中哪种类型最具吸引力？
基于应用的市场区隔是什么？
胰臟癌治疗和诊断市场中最有吸引力的应用是什么？
全球胰臟癌治疗与诊断市场的竞争结构如何？
谁是全球胰臟癌治疗和诊断市场的主要参与者/公司？

北美洲
- 美国
- 加拿大
亚太
- 中国
- 日本
- 印度
- 韩国
- 澳洲
- 印尼
- 其他的
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 俄罗斯
- 其他的
拉丁美洲
- 巴西
- 墨西哥
- 其他的
中东和非洲
- 市场趋势
- 市场细分：按国家/地区
- 市场预测

第 9 章：驱动因素、限制与机会

概述
司机
限制
机会

第 10 章：价值链分析

第 11 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 12 章：价格分析

第13章：竞争格局

市场结构
关键参与者
关键参与者简介
- AstraZeneca plc
- F. Hoffmann-La Roche Ltd.
- Immunovia AB
- Novartis AG
- Pfizer Inc.

简介目录图表

Product Code: SR112025A7538

The global pancreatic cancer therapeutics and diagnostics market size reached USD 4.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.19% during 2025-2033. The burgeoning healthcare industry, rising prevalence of pancreatic cancer, and the escalating demand for chemotherapy to kill pancreatic cancer cells represent some of the key factors driving the market.

Pancreatic cancer therapeutics and diagnostics are medical procedures used to diagnose pancreatic cancer and provide treatment. These therapeutics and diagnostics comprise ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. They rely on an endoscopic ultrasound (EUS) that uses an ultrasound device to produce images of the pancreas from inside the abdomen. They help in monitoring the location of the tumor due to an uncontrollable growth of cells in the pancreas. They assist in performing a biopsy to remove a small sample of tissue for examination under a microscope. They also aid in laboratory investigations, such as a complete blood count (CBC), liver enzyme tests for biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. As a result, pancreatic cancer therapeutics and diagnostics find applications in hospitals and specialty centers across the globe.

Pancreatic Cancer Therapeutics and Diagnostics Market Trends:

At present, the rising prevalence of pancreatic cancer due to the increasing geriatric population and excessive smoking habits among the masses represents one of the key factors supporting the growth of the market. Besides this, there is an increase in the development of molecular biology, drugs, and diagnostic technology around the world. This, along with the thriving healthcare industry, is currently propelling the growth of the market. In addition, the escalating demand for chemotherapy to kill pancreatic cancer cells by preventing them from growing and dividing is positively influencing the market. Moreover, governing agencies of several countries are extensively investing in pancreatic cancer clinical trial testing and deoxyribonucleic acid (DNA) repair inhibitors combined with chemotherapy. They are also focusing on enhancing the growth of pancreatic cancer therapeutics and diagnostics by approving drugs in the clinical phase. Apart from this, key players operating in the industry are introducing a humanized monoclonal antibody that promotes the anti-tumor immune response for treating esophageal and gastroesophageal junction and pancreatic cancer. They are also developing and introducing kit-based testing to detect pancreatic cancer by determining BRCA1 and BRCA2 variants and assessing genomic instability, which is projected to contribute to the growth of the market in the coming years.

Key Market Segmentation:

Type Insights:

Diagnostics
Imaging
Biopsy
Endoscopic Ultrasound
Others
Treatment
Targeted Therapies
Chemotherapy
Surgery
Others

Application Insights:

Hospitals
Clinics
Others

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pancreatic cancer therapeutics and diagnostics. Some of the factors driving the North America pancreatic cancer therapeutics and diagnostics market included advancements in diagnostic technologies, emerging therapies and treatment options, increasing healthcare expenditure, and government initiatives and funding.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global pancreatic cancer therapeutics and diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies include AstraZeneca plc, F. Hoffmann-La Roche Ltd., Immunovia AB, Novartis AG, Pfizer Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global pancreatic cancer therapeutics and diagnostics market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global pancreatic cancer therapeutics and diagnostics market?
What are the key regional markets?
Which countries represent the most attractive pancreatic cancer therapeutics and diagnostics markets?
What is the breakup of the market based on the type?
Which is the most attractive type in the pancreatic cancer therapeutics and diagnostics market?
What is the breakup of the market based on the application?
Which is the most attractive application in the pancreatic cancer therapeutics and diagnostics market?
What is the competitive structure of the global pancreatic cancer therapeutics and diagnostics market?
Who are the key players/companies in the global pancreatic cancer therapeutics and diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Pancreatic Cancer Therapeutics and Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Diagnostics
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Imaging
  - 6.1.2.2 Biopsy
  - 6.1.2.3 Endoscopic Ultrasound
  - 6.1.2.4 Others
- 6.1.3 Market Forecast
6.2 Treatment
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Targeted Therapies
  - 6.2.2.2 Chemotherapy
  - 6.2.2.3 Surgery
  - 6.2.2.4 Others
- 6.2.3 Market Forecast

7 Market Breakup by Application

7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Clinics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 AstraZeneca plc
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 F. Hoffmann-La Roche Ltd.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Immunovia AB
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
- 13.3.4 Novartis AG
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Pfizer Inc.
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

简介目录图表

List of Figures

Figure 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Type (in %), 2024
Figure 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2024
Figure 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2024
Figure 7: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Pancreatic Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Pancreatic Cancer Therapeutics and Diagnostics (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Pancreatic Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Pancreatic Cancer Therapeutics and Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Pancreatic Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: North America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: North America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: United States: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: United States: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Canada: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Asia-Pacific: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: China: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: China: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Japan: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: India: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: India: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: South Korea: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Australia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Indonesia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Europe: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Germany: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: France: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: France: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: United Kingdom: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Italy: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Spain: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Russia: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Latin America: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Brazil: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Mexico: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2024
Figure 65: Middle East and Africa: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
Figure 67: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
Figure 68: Global: Pancreatic Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Pancreatic Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Competitive Structure
Table 6: Global: Pancreatic Cancer Therapeutics and Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219